The Indian pharmaceutical landscape presents a complex picture, increasingly characterized by concerns surrounding monopolistic practices. While the country is lauded as a global drug powerhouse and a crucial source of affordable medicines, a growing number of observers are highlighting the tendency for a few large firms to control significant mark

India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of market concentration that warrants scrutiny. These traditional companies, including organizat